Bambusa Therapeutics

Drug Discovery · Boston, MA · Founded 2024 · Privately Held (backing)

Operator of a biotechnology company intended to create bispecific antibodies for treating immunological and inflammatory disorders. Bambusa Therapeutics is based in Boston, MA and was founded in 2024. It was valued at $555 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $143 million across 4 recorded rounds; the latest was a $40 million Series A2 in Oct 2025.

PMV mark · valuation
$555.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$143.0M
Last round
Early Stage VC (Series A2)
Oct 2025
How much has Bambusa Therapeutics raised?
$143.0Macross 4 recorded rounds · Jun 2024 – Oct 2025

Most recently, Bambusa Therapeutics raised $40.0M in its Early Stage VC (Series A2) (Oct 2025).

Free account
More of Bambusa Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Bambusa Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Bambusa Therapeutics round by round

4 rounds
Oct 2025Early Stage VC (Series A2)$40.0M▮
+ 1 more investors · free account
Feb 2025Early Stage VC (Series A)$88.9M▮
+ 1 more investors · free account
Jun 2024Early Stage VC$9.0MSEC filing▮
9 investors participated
Jun 2024Early Stage VC$5.1MSEC filing▮
4 investors participated

How much has Bambusa Therapeutics raised?

Bambusa Therapeutics has raised $143 million across 4 recorded rounds since 2024. The largest was a $9 million early-stage round in Jun 2024; the most recent was a $40 million Series A2 in Oct 2025.

Bambusa Therapeutics has filed 3 Form Ds with the SEC, most recently in Feb 2025 ($53.3 million sold to 16 investors).

Bambusa Therapeutics investors

11 investors are on record for Bambusa Therapeutics, including RA Capital Management, The Invus Group, INCE Capital and Redmile Group. The Series A2 in Oct 2025 drew 9 investors.

For fundraisers
Raising for a company like Bambusa Therapeutics?

11 investors have backed Bambusa Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 11 investors →

Frequently asked about Bambusa Therapeutics

How much has Bambusa Therapeutics raised?
Bambusa Therapeutics has raised $143.0M in total across 4 recorded funding rounds.
When was Bambusa Therapeutics's last funding round?
Bambusa Therapeutics's most recent recorded round was Early Stage VC (Series A2) in Oct 2025, raising $40.0M.